Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.65 AUD | -1.21% | -1.66% | -11.25% |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Sales 2024 * | 993M 647M | Sales 2025 * | 1.05B 682M | Capitalization | 1.5B 978M |
---|---|---|---|---|---|
Net income 2024 * | 101M 65.84M | Net income 2025 * | 117M 76.27M | EV / Sales 2024 * | 1.88 x |
Net Debt 2024 * | 368M 240M | Net Debt 2025 * | 327M 213M | EV / Sales 2025 * | 1.75 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
12.9
x | Employees | 1,996 |
Yield 2024 * |
3.93% | Yield 2025 * |
4.54% | Free-Float | 95.34% |
Latest transcript on GUD Holdings Limited
1 day | -1.21% | ||
1 week | -1.66% | ||
Current month | -9.75% | ||
1 month | -10.43% | ||
3 months | -11.98% | ||
6 months | -3.09% | ||
Current year | -11.25% |
Managers | Title | Age | Since |
---|---|---|---|
Graeme Whickman
CEO | Chief Executive Officer | - | 18-09-30 |
Director of Finance/CFO | - | 11-12-31 | |
Anne Mustow
IRC | Investor Relations Contact | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Pollaers
BRD | Director/Board Member | 62 | 21-06-22 |
Graeme Billings
CHM | Chairman | 68 | 11-12-19 |
David Robinson
BRD | Director/Board Member | 75 | 11-12-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 7 M€ | +1.38% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 10.65 | -1.21% | 154,995 |
24-04-23 | 10.78 | +0.09% | 224,352 |
24-04-22 | 10.77 | +2.47% | 108,195 |
24-04-19 | 10.51 | -2.95% | 249,709 |
24-04-18 | 10.83 | +1.03% | 188,777 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.25% | 974M | |
+31.01% | 54.1B | |
+25.77% | 20.54B | |
-21.83% | 19.47B | |
+2.95% | 16.05B | |
+19.68% | 15.77B | |
-19.29% | 13.52B | |
+32.55% | 12.18B | |
+22.85% | 10.87B | |
+24.71% | 10.31B |
- Stock Market
- Equities
- GUD Stock